Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Hiroko Kato-Hayashi"'
Autor:
Nonoko Ishihara, Shuji Yamashita, Shizuno Seiki, Keito Tsutsui, Hiroko Kato-Hayashi, Shuji Sakurai, Kyoko Niwa, Takuyoshi Kawai, Junko Kai, Akio Suzuki, Hideki Hayashi
Publikováno v:
Pharmacy, Vol 12, Iss 3, p 80 (2024)
Glucocorticoid-induced osteoporosis (GIOP) is a side effect of glucocorticoid (GC) treatment; however, despite established prevention guidelines in various countries, a gap persists between these guidelines and clinical practice. To address this gap,
Externí odkaz:
https://doaj.org/article/dee0daf3725e42cb9aa7ec0f3826fdd2
Autor:
Hironori Fujii, Yukino Ueda, Chiemi Hirose, Koichi Ohata, Kumiko Sekiya, Mika Kitahora, Shiori Sadaka, Senri Yamamoto, Daichi Watanabe, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Miho Kaburaki, Nobuhisa Matsuhashi, Takao Takahashi, Akitaka Makiyama, Kazuhiro Yoshida, Hideki Hayashi, Akio Suzuki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided by pharmacists in col
Externí odkaz:
https://doaj.org/article/3e27ad5d37c74e7f8a5a46f83069ed5b
Autor:
Hironori Fujii, Maaya Koda, Shiori Sadaka, Koichi Ohata, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Takuma Ishihara, Shinya Uemura, Takuji Iwashita, Hideki Hayashi, Tadashi Sugiyama, Masahito Shimizu, Akio Suzuki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Cancer chemotherapy usually improves clinical outcomes in patients with advanced pancreatic cancer (APC), but can also cause moderate-to-severe adverse events (AEs). We investigated the relationship between moderate-to-severe AEs
Externí odkaz:
https://doaj.org/article/20cd3bc9f2cc45b9849e89ea00afb9ea
Autor:
Yamada, Yunami, Kobayashi, Ryo, Yamamoto, Taishi, Fujii, Hironori, Iihara, Hirotoshi, Hiroko, Kato-Hayashi, Nishida, Shohei, Hoshino, Ryo, Niwa, Takashi, Kumada, Keisuke, Shimizu, Masahito, Suzuki, Akio
Publikováno v:
Journal of Pharmaceutical Health Care & Sciences; 4/26/2024, Vol. 10 Issue 1, p1-9, 9p
Autor:
Akane, Uno, Senri, Yamamoto, Hirotoshi, Iihara, Hironori, Fujii, Chiyoko, Makita, Yoh, Hayasaki, Yukino, Ueda, Masaya, Ito, Motoki, Takenaka, Tomoyasu, Kumano, Minako, Mori, Moeka, Yasue, Hiroko, Kato-Hayashi, Ryo, Kobayashi, Ken-Ichirou, Morishige, Masayuki, Matsuo, Hideki, Hayashi, Akio, Suzuki
Publikováno v:
Anticancer Research. 42:3117-3123
Nausea and vomiting are two of the most distressing adverse events of cancer radiotherapy. The aim of this study was to examine the control rate and risk factors associated with nausea and vomiting in patients with cervical cancer receiving radiother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54367b935a12b63467c432166b37b4bc
https://doi.org/10.21873/anticanres.15800
https://doi.org/10.21873/anticanres.15800
Autor:
Shiori Sadaka, Takuji Iwashita, Hironori Fujii, Hiroko Kato-Hayashi, Koichi Ohata, Shinya Uemura, Masahito Shimizu, Akio Suzuki
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5895
Modified FOLFIRINOX (mFFX) and Gemcitabine plus nab-paclitaxel (GnP) are effective first-line chemotherapies for unresectable advanced pancreatic cancer (APC); however, both lead to peripheral neuropathy (PN). Aims: To evaluate the impact of first-li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596d25f17fe3e75fdb2fd352fa58ff3b
https://pubmed.ncbi.nlm.nih.gov/36233762
https://pubmed.ncbi.nlm.nih.gov/36233762
Autor:
Shiori Sadaka, Hideki Hayashi, Hirotoshi Iihara, Maaya Koda, Shinya Uemura, Hiroko Kato-Hayashi, Akio Suzuki, Hironori Fujii, Ryo Kobayashi, Tadashi Sugiyama, Takuma Ishihara, Masahito Shimizu, Takuji Iwashita, Koichi Ohata
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-7 (2021)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background Cancer chemotherapy usually improves clinical outcomes in patients with advanced pancreatic cancer (APC), but can also cause moderate-to-severe adverse events (AEs). We investigated the relationship between moderate-to-severe AEs and quali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6476c29fc7be629e764cc5615f0d515d
https://doaj.org/article/20cd3bc9f2cc45b9849e89ea00afb9ea
https://doaj.org/article/20cd3bc9f2cc45b9849e89ea00afb9ea
Autor:
Hironori Fujii, Hitomi Teramachi, Takashi Ibuka, Ryo Kobayashi, Jun Takada, Hirotoshi Iihara, Shuji Yamashita, Yoko Ino, Masashi Ishihara, Hirofumi Tamaki, Masaya Kubota, Keiko Suzuki, Kazuhiro Iguchi, Shohei Nishida, Yoshihiro Noguchi, Hiroko Kato-Hayashi, Miyui Funato, Koji Yasuda, Masahito Shimizu, Tomoyo Yamauchi, Chiemi Hirose, Akio Suzuki, Hiroshi Araki
Publikováno v:
Journal of Pharmacy Practice and Research. 51:374-380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58e444e682bdb76e60cb9414e443e0e8
https://doi.org/10.1002/jppr.1712
https://doi.org/10.1002/jppr.1712
Autor:
Hisashi Tsurumi, Senji Kasahara, Yasuyuki Nagata, Hiroko Kato-Hayashi, Yoshinori Itoh, Michio Sawada, Masahito Shimizu, Koichi Ohata, Akio Suzuki, Hideki Hayashi, Takaaki Ono, Ryo Kobayashi, Junichi Kitagawa
Publikováno v:
International Journal of Cancer. 148(6):1462-1469
Oral mucositis is a common and distressing complication in patients receiving high-dose chemotherapy followed by hematopoietic stem cell transplantation (HSCT). We reported previously in a single-center retrospective analysis that zinc-L-carnosine (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b481e0c7e0ac18cb2c31ed6a332afbd1
http://hdl.handle.net/10271/00003903
http://hdl.handle.net/10271/00003903
Autor:
Kazuhiro Yoshida, Akitaka Makiyama, Miho Kaburaki, Senri Yamamoto, Nobuhisa Matsuhashi, Takao Takahashi, Hirotoshi Iihara, Yukino Ueda, Kumiko Sekiya, Daichi Watanabe, Shiori Sadaka, Koichi Ohata, Chiemi Hirose, Hideki Hayashi, Ryo Kobayashi, Hironori Fujii, Akio Suzuki, Mika Kitahora, Hiroko Kato-Hayashi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences. 8
Background The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided by pharmacists in collaboratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb9155eb8ddf07d95c675f213a8d9e9
https://doi.org/10.1186/s40780-022-00239-w
https://doi.org/10.1186/s40780-022-00239-w